Table 2.

Polymeric nanoparticles for antimicrobial drug delivery

Function	Nanoparticle	Drug	Targeted microorganisms	Activity and features	Ref.
Antibacterial	Poly‐lactic acid (PLA)	Arjunglucoside	Leishmania donovani	Reduced toxicity	74
	Poly‐d‐l‐lactide‐co‐glycolide (PLGA)	Gentamicin	P. aeruginosa	Controlled antibiotic release Improved antimicrobial effects	71
	Poly‐d‐l‐glycolide (PLG)	Econazole Moxifloxacin	Mycobacterium tuberculosis	Prolonged therapeutic drug levels Decreased dosage frequency	75
	Polyethylene glycol (PEG)‐PLA	Halofantrine	Plasmodiumberghe	Extended blood circulation half‐life	76
	Alginate	Rifampicin Pyrazinamide	Mycobacterium tuberculosis	Protection of drugs Controlled drug release Improved antimicrobial effects	77
Antifungal	Poloxamer 188 coated poly(epsilon‐caprolactone)78	Amphotericin B	Candida albicans	Decrease toxicity via reduced accumulation in liver and kidney	79
Antiviral	β‐cyclodextrin‐poly(a‐acryloylmorpholine)	Acyclovir	HSV‐1 and HSV‐2	Improved antiviral activity	73
	Polyhexycyanocrylate	Saquinavir	HIV	Improved delivery of antivirals	80

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.